Optimizing the Use of BTK Inhibitors in B-Cell Malignancies: Insights for the Multidisciplinary Team

Hear the latest data from lymphoma experts on the use of BTK inhibitors for chronic lymphocytic leukemia mantle cell lymphoma and other B-cell malignancies in this live case-based interactive local event and then download the meeting slideset for use in your own presentations.

Share

Program Content

Activities

BTKi in B-Cell Malignancies
Optimizing the Use of BTK Inhibitors in B-Cell Malignancies: Insights for the Multidisciplinary Team
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 10, 2018

Expires: September 09, 2019

No activities added yet

Faculty

cover img faculity

Christopher R. Flowers, MD, MS

Department Chair
Department of Lymphoma/Myeloma, Division of Cancer Medicine
University of Texas MD Anderson Cancer Center
Houston, Texas

cover img faculity

Andrew D. Zelenetz, MD, PhD

Associate Professor, Department of Medicine
Cornell University Medical College
Chief, Lymphoma Service
Memorial Sloan-Kettering Cancer Center
New York, New York

Provided by

ProCE Banner

Supporters

This activity is supported by an educational grant from

AstraZeneca